PROJECT

Projects

Summary of Investment Information

Project Number

49792

Company Name

PT Etana Biotechnologies Indonesia

Date SPI Disclosed

May 13, 2025

Country

Indonesia

Region

East Asia and the Pacific

Projected Board Date

Jun 25, 2025

Environmental Category

B - Limited

Status

Pending Signing

Last Updated Date

Jul 4, 2025

Department

Regional Industry - MAS Asia & Pac

Industry

other

Previous Events

Approved : Jul 3, 2025

Sector

other

Project Description

 Etana is a leading pharmaceutical company in Indonesia with vaccine and pharmaceutical products focused on the treatment and prevention of various (i) non-communicable diseases, including cancer and kidney disease, and (ii) infectious diseases. The Project will support the Company’s expansion plans to increase local production capacity of vaccines and biological drugs.

Associated Advisory Engagement

 Over the past three years, Etana had participated in (i) the Indonesian Health Sector Growth Program (#608036), which aims at bolstering greater private sector-led healthcare manufacturing in Indonesia, and (ii) the ASEAN Vaccine Development and Manufacturing Research Project (#178092), which aims at strengthening the commercial viability of regional vaccine production and enhance coordination among countries in Southeast Asia for vaccine procurement.

Sponsor / Cost / Location

Development Impact

E&S Category Rationale / Risks and Mitigation